Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion description "[These findings suggest that novel drugs to antagonize PPARalpha, other than the PPARgamma signalling system, may also need to be considered in the treatment or prevention of Graves' ophthalmopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion evidence source_evidence_literature NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion SIO_000772 15291748 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion wasDerivedFrom befree-2016 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_assertion wasGeneratedBy ECO_0000203 NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.
- befree-2016 importedOn "2016-02-19" NP454528.RAZLFTAloCTYwwuTNG0mS7J8sGLJN1et01deL0cDpHpXU130_provenance.